Correlates of Viral Load Suppression Among People Living with HIV on Antiretroviral Treatment in Mbujimayi, Democratic Republic of Congo: A Cross-Sectional Study

Why It Matters

The findings demonstrate that behavioral interventions are as critical as medication for HIV control, guiding public‑health strategies in resource‑limited settings.

Key Takeaways

• ART adherence increases suppression odds elevenfold
• No casual partners doubles suppression likelihood
• Condom use raises suppression odds by 76%
• Longer ART duration improves viral suppression
• Alcohol abstinence cuts non‑suppression risk in half

Pulse Analysis

The quest for durable viral load suppression remains the cornerstone of modern HIV management, especially in low‑resource environments where treatment gaps translate into higher morbidity and transmission rates. In the Democratic Republic of Congo, a nation grappling with fragmented health infrastructure and a growing epidemic, understanding why some patients on antiretroviral therapy (ART) fail to achieve undetectable viral loads is critical. Recent research from Mbujimayi sheds light on the interplay between clinical adherence and everyday behaviors, offering data that can refine regional HIV strategies. The approach, merging viral load data with behavioral questionnaires, offers a template for similar settings.

The cross‑sectional analysis of 561 individuals revealed that strict ART adherence was the most powerful predictor, boosting suppression odds by more than eleven times. Equally influential were stable sexual practices: participants without casual partners were twice as likely to suppress the virus, and consistent condom use added a 76 % advantage. Each additional year on therapy modestly increased success, while abstaining from alcohol halved the odds of non‑suppression. The condom effect remained significant after controlling for age, gender, and disease stage, underscoring that biomedical efficacy alone is insufficient; behavioral stewardship directly shapes treatment outcomes in resource‑constrained clinics.

Policymakers can translate these insights into targeted interventions: intensified adherence counseling, community‑based peer support, and integrated sexual‑health education that promotes condom use and discourages casual encounters. Embedding alcohol‑screening modules within routine ART visits could further reduce viral rebound risk. As the DRC scales up its ‘Test‑Treat‑Track’ agenda, aligning funding with behavioral‑change programs promises a higher return on investment than medication alone. Mobile reminder apps could further boost adherence among younger patients facing stigma, while future longitudinal studies should explore how these determinants evolve with newer regimen options and digital adherence tools.